Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 21 studies | 52% ± 17% | |
peripheral blood | 19 studies | 60% ± 15% | |
intestine | 14 studies | 44% ± 20% | |
kidney | 9 studies | 43% ± 20% | |
liver | 7 studies | 37% ± 15% | |
lymph node | 7 studies | 49% ± 28% | |
uterus | 6 studies | 52% ± 18% | |
brain | 6 studies | 31% ± 10% | |
pancreas | 5 studies | 38% ± 10% | |
placenta | 5 studies | 42% ± 15% | |
eye | 5 studies | 28% ± 10% | |
skin | 5 studies | 49% ± 12% | |
breast | 5 studies | 61% ± 15% | |
bone marrow | 4 studies | 51% ± 20% | |
heart | 4 studies | 22% ± 3% | |
adipose | 4 studies | 42% ± 16% | |
esophagus | 4 studies | 47% ± 17% | |
prostate | 4 studies | 50% ± 12% | |
stomach | 4 studies | 26% ± 12% | |
ovary | 3 studies | 28% ± 7% | |
adrenal gland | 3 studies | 56% ± 23% | |
thymus | 3 studies | 46% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 16761.71 | 1443 / 1445 | 100% | 110.20 | 183 / 183 |
intestine | 100% | 16264.07 | 964 / 966 | 99% | 107.99 | 523 / 527 |
breast | 100% | 30633.10 | 459 / 459 | 99% | 114.64 | 1106 / 1118 |
bladder | 100% | 19634.67 | 21 / 21 | 99% | 106.26 | 498 / 504 |
lung | 100% | 25916.02 | 578 / 578 | 99% | 88.56 | 1140 / 1155 |
skin | 100% | 31644.33 | 1809 / 1809 | 95% | 89.79 | 449 / 472 |
thymus | 96% | 15937.45 | 630 / 653 | 97% | 140.97 | 586 / 605 |
uterus | 98% | 15811.53 | 167 / 170 | 95% | 87.64 | 436 / 459 |
ovary | 96% | 9817.94 | 173 / 180 | 95% | 73.29 | 410 / 430 |
kidney | 92% | 11946.35 | 82 / 89 | 98% | 215.93 | 887 / 901 |
stomach | 89% | 12408.01 | 320 / 359 | 99% | 104.47 | 284 / 286 |
pancreas | 76% | 7177.66 | 250 / 328 | 98% | 133.21 | 174 / 178 |
prostate | 76% | 5998.90 | 187 / 245 | 87% | 60.19 | 436 / 502 |
liver | 61% | 7958.23 | 138 / 226 | 86% | 63.93 | 351 / 406 |
brain | 12% | 691.81 | 310 / 2642 | 90% | 48.04 | 633 / 705 |
adipose | 100% | 38181.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 8957.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 83.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.57 | 1 / 1 |
blood vessel | 100% | 23137.86 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 16155.45 | 893 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 30% | 2171.11 | 77 / 258 | 63% | 33.34 | 145 / 230 |
muscle | 88% | 11126.02 | 707 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 46.19 | 23 / 29 |
heart | 76% | 6135.21 | 655 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 71% | 31.58 | 57 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030183 | Biological process | B cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005730 | Cellular component | nucleolus |
GO_0001650 | Cellular component | fibrillar center |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KLF6 |
Protein name | Kruppel-like factor 6 variant SV2 Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) |
Synonyms | ST12 CPBP BCD1 COPEB |
Description | FUNCTION: Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development. . |
Accessions | ENST00000542957.1 [Q99612-3] D3GC14 Q99612 ENST00000469435.1 [Q99612-2] ENST00000497571.6 [Q99612-1] |